Industry News
Revised code to benefit ASX-listed life science companies
The Minister for Technology, the Hon Gordon Rich-Phillips, yesterday joined forces with the Australian Securities Exchange (ASX) and Australia’s biotechnology industry association, AusBiotech, to launch a revised edition of the industry code of best practice that will support capital formation by ASX-listed life science companies. [ + ]
pSivida posts $2.8m loss for Q3
pSivida (ASX:PVA) says its net loss grew slightly in Q3, as it awaits revenue and royalty payments from partner Alimera for the Iluvien insert. [ + ]
Partnership in sleep-disordered breathing
The University of Sydney and ResMed have created a new partnership that will support research into sleep disorders. [ + ]
Brain rewiring
A collaborative research project has advanced our understanding of brain plasticity. [ + ]
REVA appoints new managing director
Michel Vanbrabant will joint REVA Medical (ASX:RVA) as managing director to help the company prepare its EU market strategy for bioresorbable coronary scaffold ReZolve2. [ + ]
Science Budget lacks vision for Australia’s future, says science academy
The Australian Academy of Science has said the short-sighted 2013 federal science Budget failed to take a visionary approach to securing the nation’s future and economic, social and environmental wellbeing. [ + ]
Cocaine vaccine passes key testing hurdle
Researchers at Weill Cornell Medical College have successfully tested their novel anti-cocaine vaccine in primates, bringing them closer to launching human clinical trials. [ + ]
Redefining the ampere
The world’s first graphene single-electron pump provides the speed of electron flow needed to create a new standard for electrical current based on electron charge. [ + ]
Bioniche to sell animal health division
Bioniche (ASX:BNC) has hired an adviser to help it negotiate a sale of its animal health division and has received two preliminary partnership offers for bladder cancer treatment Urocidin. [ + ]
Mercury Capital invests in Novotech
PE firm Mercury Capital has acquired a 30% stake in incumbent Australian CRO Novotech, with the option to increase its holding to 50%. [ + ]
AU boffins develop bacteria-killing Trojan horse
Scientists from UOW and UNSW have patented a new drug technology for combating antibiotic-resistant bacteria, developed by thinking like the enemy. [ + ]
Bringing stem cell researchers together
This week, experts from around Australia and two international leaders in the field will meet to discuss stem cell science and just how close we are to delivering on the promise of this field. [ + ]
BioDiem moves to animal trials in pneumocystosis
BioDiem (ASX:BDM) has said its antimicrobial candidate BDM-I is ready for preclinical trials against Pneumocystosis, a parasitic fungus that can cause pneumonia. [ + ]
National Centre for Neuroimmunology and Emerging Diseases
A new centre dedicated to research on the interaction between the nervous system and the immune system has been established on the Gold Coast. [ + ]
The social lives of plants
Having a neighbourly chat improves seed germination in plants. [ + ]
